Molina Healthcare, Inc. (NYSE:MOH) Shares Purchased by Quantinno Capital Management LP

Quantinno Capital Management LP grew its position in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 300.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 21,690 shares of the company's stock after purchasing an additional 16,277 shares during the quarter. Quantinno Capital Management LP's holdings in Molina Healthcare were worth $6,313,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of the company. Mufg Securities Americas Inc. purchased a new position in Molina Healthcare during the 4th quarter worth $246,000. Man Group plc raised its position in Molina Healthcare by 143.5% during the fourth quarter. Man Group plc now owns 41,273 shares of the company's stock worth $12,013,000 after acquiring an additional 24,323 shares during the last quarter. Nissay Asset Management Corp Japan ADV raised its position in shares of Molina Healthcare by 1.1% in the fourth quarter. Nissay Asset Management Corp Japan ADV now owns 7,285 shares of the company's stock valued at $2,129,000 after buying an additional 79 shares during the last quarter. Nomura Holdings Inc. acquired a new position in Molina Healthcare during the fourth quarter worth approximately $547,000. Finally, NorthRock Partners LLC purchased a new stake in Molina Healthcare during the fourth quarter worth approximately $206,000. 98.50% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Molina Healthcare

In other Molina Healthcare news, CEO Joseph M. Zubretsky sold 87,500 shares of the company's stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $320.06, for a total value of $28,005,250.00. Following the completion of the sale, the chief executive officer now owns 257,715 shares of the company's stock, valued at $82,484,262.90. This represents a 25.35% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Richard M. Schapiro sold 669 shares of the firm's stock in a transaction on Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total value of $214,414.50. Following the transaction, the director now directly owns 11,244 shares of the company's stock, valued at $3,603,702. This represents a 5.62% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 89,169 shares of company stock worth $28,520,995 in the last ninety days. Company insiders own 1.10% of the company's stock.

Molina Healthcare Price Performance

Shares of MOH stock traded up $1.03 on Tuesday, reaching $326.38. The company had a trading volume of 522,052 shares, compared to its average volume of 688,395. The business's 50-day moving average is $324.27 and its 200 day moving average is $308.22. The stock has a market capitalization of $17.69 billion, a PE ratio of 15.98, a price-to-earnings-growth ratio of 1.06 and a beta of 0.63. Molina Healthcare, Inc. has a one year low of $262.32 and a one year high of $365.23. The company has a quick ratio of 1.62, a current ratio of 1.62 and a debt-to-equity ratio of 0.69.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings data on Wednesday, April 23rd. The company reported $6.08 EPS for the quarter, topping the consensus estimate of $5.96 by $0.12. Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. The company had revenue of $11.15 billion during the quarter, compared to the consensus estimate of $10.86 billion. During the same quarter last year, the firm posted $5.73 EPS. The company's quarterly revenue was up 12.2% on a year-over-year basis. Equities research analysts forecast that Molina Healthcare, Inc. will post 24.4 EPS for the current fiscal year.

Analysts Set New Price Targets

MOH has been the topic of a number of research reports. Wells Fargo & Company raised shares of Molina Healthcare from an "equal weight" rating to an "overweight" rating and increased their target price for the stock from $295.00 to $372.00 in a report on Wednesday, March 5th. UBS Group dropped their price objective on Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating on the stock in a report on Friday, February 7th. Barclays increased their price target on Molina Healthcare from $339.00 to $362.00 and gave the company an "equal weight" rating in a report on Friday, April 25th. StockNews.com raised Molina Healthcare from a "hold" rating to a "buy" rating in a research report on Friday, April 11th. Finally, Sanford C. Bernstein began coverage on Molina Healthcare in a report on Tuesday, April 22nd. They set an "outperform" rating and a $414.00 price objective for the company. Nine equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $365.38.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.